Stephanie McCarter, MD
Stephanie McCarter MD is board certified in Internal Medicine and currently practices Internal Medicine and Environmental Medicine with fifteen years of experience working with world renown environmental medicine physician, Dr. William Rea. She is a member of the American College of Physicians, the Alpha Omega Alpha Honor Medical Society, the American Academy of Environmental Medicine, the International Society for Environmentally Acquired Illness, and on the board of the National Association of Environmental Medicine. She graduated from Indiana University School of Medicine in 1993 and from Pepperdine University in 1989.
She has built her own eco-friendly, low-electromagnetic-field home, consulting with well-known experts in healthy house building, including David Rousseau and Tang Lee of Canada, and Mary Oetzel in Texas.
She has lectured on Environmental Medicine in the areas of indoor/outdoor air quality, avoiding pollutants in air, food and water, evaluation and treatment of electromagnetic field sensitivity, and on preparing antigens for provocation/neutralization immunotherapy.
Dr. McCarter believes that the body is an energetically open system that is exchanging energy and materials with its surrounding environment and must be treated as such to achieve total wellness. She strongly believes such treatment should be of the whole body, mind, and spirit.
EMF Sensitivity Treatment Modalities
Treatment of electromagnetic (EMF) sensitivity is a multidisciplinary approach. EMF sensitivity involves systemic inflammation triggered by an overload of total pollutants and toxins that affect many of the bodily systems and possible infections. Each patient is unique and the causes and symptoms of EMF sensitivity vary among patients. Patient case studies are presented which involve taking a detailed history of exposures and sensitivities to physical EMF fields, molds and mycotoxins, chemicals, and heavy metals. Double blind EMF testing is performed in an environmentally controlled and shielded environment. Diagnostic testing involves evaluating inflammatory markers, all parts of the immune system, and testing for infections. Nutrient testing, as well as solvent, heavy metal, mold and mycotoxin, and chemical profiles are performed.
Treatment for EMF sensitive patients involves optimizing the immune system by a booster made from the patient’s own blood called autogenous lymphocytic factor (Alf) and treating immunoglobulin deficiencies. Provocation neutralization (P / N) skin testing in a controlled environment is used to identify and treat the elements that are triggering a patient’s immune, endocrine, vascular, and nervous systems. These triggers include heavy metals, molds, mycotoxins, pollens, foods, chemicals, and dental and implant materials. P / N is also used for treating imbalances of neurotransmitters which include histamine, serotonin, and capsaicin. Treatment also includes intravenous chelation with EDTA, DMSA and alpha lipoic acid for heavy metals and IV nutritional therapy. P / N skin testing is often used to de sensitize patients to sensitivities to intravenous nutrients agents and chelating agents before treatment to optimize treatment benefit. Von Ardenne’s oxygen therapy is used when applicable to treat patients with a unique low chemical apparatus. Sauna and lymphatic massage are recommended based on the patient’s detoxification capacity and total load evaluation. Ozone therapy both with insufflation and intravenous ozone are used when applicable. In some cases patients can tolerate bioregulation therapy (BRT) or microcurrent therapy to help support communication and detoxification at the cellular level.
Patients are educated about resources for lowering physical EMF exposure in their home and methods to help ground their energy and lower EMF symptoms. Information from the patient’s testing results which includes both lab tests and skin testing plus the patient’s exposure history in their home and work environment is used to produce a unique profile of treatment recommendations for decreasing EMF sensitivity in each patient.
Friday 29 January 2021
EMF Sensitivity Treatment Modalities